Poly Cystic Ovary Syndrome: Clinical Trials

15 trials for Poly Cystic Ovary Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 not yet recruiting, 3 recruiting, 2 active not recruiting. 7 Not applicable, 4 Phase 3, 3 Phase 2, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 4, Active not recruiting 2, Not yet recruiting 1
Phase 34Not yet recruiting 2, Recruiting 2
Phase 23Not yet recruiting 2, Recruiting 1
Phase 42Completed 1, Unknown 1
Phase 11Recruiting 1

Follow Poly Cystic Ovary Syndrome: new trials by email Literature Review of Poly Cystic Ovary Syndrome trials Research Report on Poly Cystic Ovary Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inspiratory Muscle Training for the Management of Polyendocrine Metabolic Ovarian Syndrome
Exercise - Poly Cystic Ovary Syndrome
Not applicableActive not recruitingBritish University In Egypt402026-10-072026-10-13
E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen Study
Exemestane 25 MG, Placebo, Exemestane 50 MG - Poly Cystic Ovary Syndrome
Phase 1RecruitingUniversity of North Carolina, Chapel Hill402026-10-012026-09-23
Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary Syndrome
Metformin, Vildagliptin (Galvus) - Poly Cystic Ovary Syndrome
Phase 2 / Phase 3Not yet recruitingTanta University702026-09-202026-09-21
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
Metformin, Dapagliflozin (10mg Tab) - Poly Cystic Ovary Syndrome
Phase 2 / Phase 3Not yet recruitingTanta University602026-09-102026-09-09
Physical Activity and Cardiometabolic Health in Women With or Without Polycystic Ovary Syndrome (SCOPAP)
Physical activity - Poly Cystic Ovary Syndrome, Overweight , Obesity
Not applicableNot yet recruitingUniversity Hospital, Clermont-Ferrand402026-07-012026-06-22
Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients
Myo-inositol, Folic Acid, Alpha Lipoic Acid - Poly Cystic Ovary Syndrome
Phase 3RecruitingBeni-Suef University1802026-03-102026-06-05
Myo-Inositol and Folic Acid for Improving Inflammation in Polycystic Ovary Syndrome
myo-inositol 2000 gm + folic acid 200 mcg - Inflammation Biomarkers, Poly Cystic Ovary Syndrome
Not applicableActive not recruitingKhyber Medical University Peshawar502025-10-112026-09-15
Modulation of Hyperandrogenic Anovulation Through Fenugreek Seeds
Control, Fenugreek seeds (G1):, Fenugreek seeds (G2) - Poly Cystic Ovary Syndrome
Not applicableCompletedUniversity of Lahore702024-09-112026-05-28
Effectiveness of Hatha Yoga With and Without Zumba Exercise on Clinical Outcomes in Females With Poly Cystic Ovarian Syndrome
Hatha Yoga, Zumba Exercise - Poly Cystic Ovary Syndrome
Not applicableCompletedRashid Latif Medical College542024-08-202026-01-23
Efficacy of Metformin With and Without Probiotics in Women With PCOS
Metformin, Probiotics - Poly Cystic Ovary Syndrome
Not applicableCompletedDhivyaprasath Palaniappan602024-03-272026-10-15
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
Metformin Hydrochloride tablet, Vildagliptin 50 MG - Poly Cystic Ovary Syndrome
Phase 2 / Phase 3RecruitingOctober 6 University602023-11-252025-07-30
Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
Daflon, Combined oral contraceptive, Metformin - Poly Cystic Ovary Syndrome
Phase 4UnknownAin Shams University1202023-11-012023-10-16
The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.
dry eye diagnostic system of Mediworks, Optical coherence tomography angiography, Contraceptives, Oral, Combined - Poly Cystic Ovary Syndrome
CompletedCairo University902023-06-242026-02-19
Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome
flaxseed powder - Poly Cystic Ovary Syndrome
Not applicableCompletedAllied Hospital Faisalabad1202017-03-232018-10-22
Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome
Fenugreek seeds extract 500 mg - Poly Cystic Ovary Syndrome
Phase 4CompletedChemical Resources502013-09-012016-06-03

Narrower conditions

Polycystic Ovary Syndrome (5)  ·  Anxiety Disorders (1)  ·  Dry Eye Syndromes (1)  ·  Hyperandrogenism (1)  ·  Insulin Resistance (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Pain (1)

Broader conditions

Adnexal Diseases (5)  ·  Cysts (5)  ·  Endocrine System Diseases (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Female (5)  ·  Gonadal Disorders (5)  ·  Neoplasms (5)  ·  Ovarian Cysts (5)  ·  Ovarian Diseases (5)  ·  Urogenital Diseases (5)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Metformin (5)  ·  Contraceptives, Oral, Combined (2)  ·  Exercise (2)  ·  Folic Acid (2)  ·  Vildagliptin (2)  ·  Clomiphene (1)  ·  Diosmin (1)  ·  Inositol (1)  ·  Methods (1)  ·  Probiotics (1)  ·  Thioctic Acid (1)  ·  dapagliflozin (1)  ·  exemestane (1)

Sponsors

Tanta University (2)  ·  Ain Shams University (1)  ·  Allied Hospital Faisalabad (1)  ·  Beni-Suef University (1)  ·  British University In Egypt (1)  ·  Cairo University (1)  ·  Chemical Resources (1)  ·  Dhivyaprasath Palaniappan (1)  ·  Khyber Medical University Peshawar (1)  ·  October 6 University (1)  ·  Rashid Latif Medical College (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Lahore (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

Egypt (4)  ·  Pakistan (4)  ·  France (1)  ·  India (1)  ·  United States (1)

Top investigators

Bruce Pier, MD (1)  ·  Dhivyaprasath P, Pharm D (1)  ·  Dr Amrita Sarkari Jaipuriar, MS (1)  ·  Dr Mohsin Shah, PhD (1)  ·  Dr Muzna Atif, Mphil (1)  ·  Khalid Mahmood, MPhill (1)

Results publications

PMID 26516311